The roles of cysteinyl leukotrienes in eosinophilic inflammation of asthmatic airways

International Archives of Allergy and Immunology

Volumn 131, Issue SUPPL. 1, 2003, Pages 7-10

  Nagata, Makoto ^a,b   Saito, Keiko ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b Pulmonary Division   (Japan)

Author keywords

Cell adhesion; Eosinophils; Leukotriene receptor antagonist; Leukotrienes

Indexed keywords

BECLOMETASONE; BETA2 INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIPOXYGENASE INHIBITOR; MONTELUKAST; PEPTIDOLEUKOTRIENE; PRANLUKAST; ZILEUTON;

ALLERGIC ASTHMA; CELL ACTIVATION; CELL ADHESION; CELL SURVIVAL; CHEMOTAXIS; CONFERENCE PAPER; DRUG EFFECT; DRUG EFFICACY; EOSINOPHIL; HUMAN; IMMUNOPATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SECRETION; RESPIRATORY BURST; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFLAMMATION;

AIRWAY RESISTANCE; ANIMALS; ASTHMA; BIOTRANSFORMATION; CYSTEINE; EOSINOPHILS; EVIDENCE-BASED MEDICINE; HUMANS; INFLAMMATION MEDIATORS; LEUKOTRIENES; MICE; PNEUMONIA;

EID: 0037977955     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070474     Document Type: Conference Paper

References (29)

1. Lewis RA, Austen KF, Soberma RJ: Leukotrienes and other products of the 5-lipoxygenase pathway: Biochemistry and relation to pathobiology in human diseases. N Engl J Med 1990;323:645-655.
2. Henderson WR Jr: The role of leukotrienes in inflammation. Ann Intern Med 1994;121:684-697.
3. Jeffery PK: The roles of leukotrienes and the effects of leukotriene receptor antagonists in the inflammatory response and remodeling of allergic asthma. Clin Exp Allergy Rev 2001;1:148-153.
4. 4 and granulocytes infiltration into asthmatic airways. Lancet 1993;341:989-990.
5. 4 and methacholine inhalation in patients with asthma. Am J Respir Crit Care Med 2000;162:1685-1689.
6. 4, increased airway inflammatory cells in subjects with atopic asthma. Am J Respir Crit Care Med 2001;164:1495-1500.
7. 4 and methacholine on cell differentials in sputum from patients with asthma. Am J Respir Crit Care Med 1997;155:1247-1253.
8. 4 in asthma. Am J Respir Crit Care Med 2001;164:202-206.
9. 4 on airway eosinophilia and airway hyperresponsiveness in asthmatic subjects. Am J Respir Crit Care Med 1999;159:1562-1567.
10. Figueroa DJ, Breyer RM, Defoe SK, Kargman S, Daugherty BL, Waldburger K, Liu Q, Clements M, Zeng Z, O'Neill GP, Jones TR, Lynch KR, Austin CP, Evans JF: Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes. Am J Respir Crit Care Med 2001;163:226-233.
11. Braccioni F, Dorman SC, O'Byrne PM, Inman MD, Denburg JA, Parameswaran K, Baatjes AJ, Foley R, Gauvreau: The effect of cysteinyl leukotrienes on growth of eosinophil progenitors from peripheral blood and bone marrow of atopic subjects. J Allergy Clin Immunol 2002;110:96-101.
12. 4 effects on human eosinophil and neutrophils motility in vitro. J Leuko Biol 1994;55:183-191.
13. Yamamoto H, Sedgwick JB, Vrtis RF, Busse WW: The effect of transendothelial migration on eosinophil function. Am J Respir Cell Mol Biol 2000;23:379-388.
14. Lee E, Robertson T, Smith J, Kilfeather S: Leukotriene receptor antagonists and synthesis inhibitors reverse survival in eosinophils of asthmatic individuals. Am J Respir Crit Care Med 2000;161:1881-1886.
15. Bandeira-Melo C, Hall JC, Penrose JF, Weller PF: Cysteinyl leukotrienes induce IL-4 release from cord blood-derived human eosinophils. J Allergy Clin Immunol 2002;109:975-979.
16. Bochner BS: Cellular adhesion and its antagonism. J Allergy Clin Immunol 1997;100:581-585.
17. Yamamoto H, Sedgwick JB, Busse WW: Differential regulation of eosinophil adhesion and transmigration by pulmonary microvascular endothelial cells. J Immunol 1998;161:971-977.
18. Nagata M, Saito K, Tsuchiya K, Sakamoto Y: Leukotriene D4 upregulates eosinophil adhesion via the cysteinyl leukotriene 1 receptor. J Allergy Clin Immunol 2002;109:676-670.
19. Fregonese L, Silvestri M, Sabatini F, Rossi GA: Cysteinyl leukotrienes induce human eosinophil locomotion and adhesion molecule expression via a CysLT1 receptor-mediated mechanism. Clin Exp Allergy 2002;32:745-750.
20. Nagata M, Sedgwick JB, Kita H, Busse WW: Granulocyte macrophage colony-stimulating factor augments ICAM-1 and VCAM-1 activation of eosinophil function. Am J Respir Cell Mol Biol 1998;19:158-166.
21. Creticos PS, Peters SP, Adkinson F, Naclerio RM, Hayes EC, Norman PS, Lichtenstein LM: Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. N Engl J Med 1984;310:1626-1630.
22. Wenzel SE, Larsen GL, Johnston K, Voelkel NF, Westcott JY: Elevated levels of leukotriene C4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge. Am Rev Respir Dis 1990;142:112-119.
23. Pavord ID, Ward R, Woltman G, Wardlaw AJ, Sheller JR, Dworski R: Induced sputum eicosanoid concentrations in asthma. Am J Respir Crit Care Med 1999;160:1905-1909.
24. MacFarlane AJ, Dworski R, Sheller JR, Pavord ID, Kay AB, Barnes NC: Sputum cysteinyl leukotrienes increase 24 hours after allergen inhalation in atopic asthmatics. Am J Respir Crit Care Med 2000;161:1553-1558.
25. Nakamura Y, Hoshino M, Sim JJ, Ishii K., Hosaka K, Sakamoto T: Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma. Thorax 1998;53:835-841.
26. Yoshida S, Ishizaki Y, Shoji T, Onuma K, Nakagawa H, Nakabayashi M, Akahori K, Hasegawa H, Amayasu H: Effect of pranlukast on bronchial inflammation in patients with asthma. Clin Exp Allergy 2000;30:1008-1014.
27. Pizzichini E, Leff JA, Reiss TF, Hendeles L, Boulet LP, Wei LX, Efthimiadis AE, Zhang J, Hargreave FE: Montelukast reduces airway eo-sinophilic inflammation in asthma: A randomized controlled trial. Eur Respir J 1999;14:12-18.
28. Wenzel SE, Trudeau JB, Kaminsky DA, Cohn J, Martin RJ: Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma. Am J Respis Crit Care Med 1995;152:897-905.
29. Laviolette M, Malmstrom K, Lu S, Chervinsky P, Pujet JC, Peszek I, Zhang J, Reiss TF: Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group. Am J Respir Crit Care Med 1999;160:1862-1868.